Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings

Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

ESMO open·2026

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

ESMO open·2025

Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.

ESMO open·2025

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Systemic pruritus as a neuroimmune disorder: Mechanistic insights and target-driven therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

IADVL consensus recommendations on Trichophyton indotineae infections: Using modified Delphi method.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Psychiatric morbidity, genetic susceptibility and the risk of vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Dental Students' Knowledge and Opinion on Optimizing Antibiotic Prophylaxis Guidelines: A Cross-Sectional Survey in India.

Cureus·2026

Utilisation and Shortages of Dental Medicines in Australia From 2014 to 2025: A Retrospective Time-Series Study.

International journal of dentistry·2026

Mechanistic insights into oxalate-based desensitizers: Calcium oxalate deposition and reduced calcium release under acid challenge.

Dental materials : official publication of the Academy of Dental Materials·2026

DT120 (MM120): a single-dose orally disintegrating formulation of lysergide tartrate for generalized anxiety disorder.

Expert review of neurotherapeutics·2026

Making a case for dental clinical practice guidelines for elective antibiotic use: an institutional retrospective study.

Quintessence international (Berlin, Germany : 1985)·2026

Orally Administered Acarbose-Guar gum Solid Dispersion mitigates diabetes-induced kidney damage via modulating inflammatory response and oxidative stress in diabetic rats.

Journal of drug targeting·2026

Related Experiment Videos

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings

Related Concept Videos

Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

Novel pembrolizumab-based treatments as first-line therapy in advanced clear-cell renal cell carcinoma: substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial.

Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa: A nationwide cohort study.

Systemic pruritus as a neuroimmune disorder: Mechanistic insights and target-driven therapy.

IADVL consensus recommendations on Trichophyton indotineae infections: Using modified Delphi method.

Psychiatric morbidity, genetic susceptibility and the risk of vitiligo.

Dental Students' Knowledge and Opinion on Optimizing Antibiotic Prophylaxis Guidelines: A Cross-Sectional Survey in India.

Utilisation and Shortages of Dental Medicines in Australia From 2014 to 2025: A Retrospective Time-Series Study.

Mechanistic insights into oxalate-based desensitizers: Calcium oxalate deposition and reduced calcium release under acid challenge.

DT120 (MM120): a single-dose orally disintegrating formulation of lysergide tartrate for generalized anxiety disorder.

Making a case for dental clinical practice guidelines for elective antibiotic use: an institutional retrospective study.

Orally Administered Acarbose-Guar gum Solid Dispersion mitigates diabetes-induced kidney damage via modulating inflammatory response and oxidative stress in diabetic rats.

Related Experiment Videos

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings

Related Concept Videos

Related Articles